Found: 8
Select item for more details and to access through your institution.
Validation of the chromogenic Bethesda assay for factor VIII inhibitors in hemophilia a patients receiving Emicizumab.
- Published in:
- 2021
- By:
- Publication type:
- Letter to the Editor
Eptifibatide-induced thrombocytopenia and thrombosis in humans require FcgammaRIIa and the integrin beta3 cytoplasmic domain.
- Published in:
- 2009
- By:
- Publication type:
- journal article
Eptifibatide-induced thrombocytopenia and thrombosis in humans require FcγRIIa and the integrin β3 cytoplasmic domain.
- Published in:
- Journal of Clinical Investigation, 2009, v. 119, n. 3, p. 504, doi. 10.1172/JCI36745
- By:
- Publication type:
- Article
Manufacturing Control System Development for an In Vitro Diagnostic Product Platform.
- Published in:
- Processes, 2021, v. 9, n. 6, p. 975, doi. 10.3390/pr9060975
- By:
- Publication type:
- Article
Blockade of maternal anti-HPA-1a–mediated platelet clearance by an HPA-1a epitope–specific F(ab′)<sub>2</sub> in an in vivo mouse model of alloimmune thrombocytopenia.
- Published in:
- Transfusion, 2009, v. 49, n. 2, p. 265, doi. 10.1111/j.1537-2995.2008.01972.x
- By:
- Publication type:
- Article
Characteristics of hemophilia patients with factor VIII inhibitors detected by prospective screening.
- Published in:
- American Journal of Hematology, 2015, v. 90, n. 10, p. 871, doi. 10.1002/ajh.24104
- By:
- Publication type:
- Article
Evaluation of anti‐factor VIII antibody levels in patients with haemophilia A receiving immune tolerance induction therapy or bypassing agents.
- Published in:
- Haemophilia, 2021, v. 27, n. 1, p. e40, doi. 10.1111/hae.14202
- By:
- Publication type:
- Article
Reagent substitution in the chromogenic Bethesda assay for factor VIII inhibitors.
- Published in:
- Haemophilia, 2019, v. 25, n. 5, p. e342, doi. 10.1111/hae.13827
- By:
- Publication type:
- Article